New Study Reveals What Happens to Your Brain on the World’s Most Powerful Psychedelic
Scientist captured the first detailed look at how 5-MeO-DMT reshapes brain activity which challenge long held assumptions.
Read More
Psilocybin Therapy Shows Promise for Binge Eating Disorder
The findings add to growing evidence that psychedelics may treat conditions long resistant to conventional approaches.
Read More
Why Timing Matters: The Science Behind Scheduling Psychotherapy After Ketamine
New insights: Should psychotherapy happen during the ketamine session, immediately after, or the following day?
Read More
Congressional Psychedelics Report Card: Who Supports and Opposes Legalization
Knowing which members of Congress will advance or block psychedelic medicine helps advocates know where to focus their energy.
Read More
Bipartisan Bill Would Let Doctors Administer MDMA and Psilocybin to Seriously Ill Patients
The Freedom to Heal Act would allow doctors to legally administer Schedule I drugs like MDMA and psilocybin to very ill patients.
Read More
Exploding Head Syndrome: Ketamine Shows Promise for Rare Sleep Disorder
A man suffering from exploding head syndrome for over five years found relief through an unexpected treatment: sublingual ketamine.
Read More
Ohio State University Launches First National Program to Train Providers on Psychedelic Crisis Response
Psychedelic use is rising across America. Ohio State University wants first responders ready for what comes next. The university announced a groundbreaking program this month. It will train 127,000 providers to handle adverse reactions to hallucinogens. The initiative marks the first of its kind in the nation. New: Interested in Being Part of a Psychedelics-Focused Clinical […]
Read More
Chinese Scientists Unlock the Mystery Behind Ketamine’s Rapid Relief for Depression
Chinese researchers have discovered a breakthrough that could transform the way ketamine can treat depression.
Read More
The Countdown to Approval: The Psychedelic Clinical Trials That Could Reshape Mental Healthcare
Multiple late-stage psychedelic trials are currently underway that could transform mental healthcare for millions of Americans.
Read More
Arizona Launches First Trial Using Whole Psilocybin Mushrooms for PTSD Treatment
Twenty four Arizonans living with post traumatic stress disorder will participate in a groundbreaking study next month.
Read More